Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal damage associated with proteinuria.

Manuel Praga1, Enrique Morales

  • 1Servicio de Nefrología, Hospital 12 de Octubre, Madrid, Spain. mpragat@senefro.org

Kidney International. Supplement
|November 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FINE-ONE, more to come: moving beyond ACEis and ARBs in type 1 diabetes with kidney disease?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

The authors reply.

Kidney international·2026
Same author

Emerging Cardiorenal Protective Therapies in Lupus Nephritis.

Drugs·2026
Same author

Short versus long corticosteroid therapy for immune checkpoint inhibitors-induced acute tubulointerstitial nephritis.

Clinical kidney journal·2026
Same author

Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?

Pediatric nephrology (Berlin, Germany)·2026
Same author

Albuminuria in Lupus Nephritis: the hidden threat to cardiovascular health.

Rheumatology advances in practice·2026
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Proteinuria damages kidneys by activating NF-kappaB. Blocking the renin-angiotensin system with ACE inhibitors or ARAs reduces proteinuria and protects kidneys, though resistance can occur. Additional therapies may enhance this effect.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Proteinuria triggers proximal tubular cell proliferation and inflammation.
  • Tubulointerstitial fibrosis in proteinuric diseases is preceded by interstitial cellular infiltrates.
  • Nuclear factor kappaB (NF-kappaB) activation is critical in proteinuria-induced renal damage.

Purpose of the Study:

  • To review the role of proteinuria in renal damage.
  • To evaluate the antiproteinuric and renoprotective effects of renin-angiotensin system blockers.
  • To discuss strategies for overcoming resistance to ACE inhibitors/ARAs.

Main Methods:

  • Review of experimental and clinical studies on proteinuria and kidney disease.
  • Analysis of the mechanisms of renal damage.

Related Experiment Videos

  • Evaluation of therapeutic interventions targeting proteinuria.

    • Main Results:

    • Glomerular protein filtration induces tubular cell proliferation and inflammation.
    • Renin-angiotensin system inhibitors (ACE inhibitors and ARAs) show significant antiproteinuric and renoprotective effects.
    • Renoprotection by ACEI/ARAs is linked to antiproteinuric effects, independent of blood pressure.

    Conclusions:

    • Reducing proteinuria is key to kidney protection.
    • ACE inhibitors and ARAs are effective in managing proteinuric kidney diseases.
    • Strategies like optimizing blood pressure, lifestyle changes, and combination therapy can improve proteinuria reduction.